HbA1c 3months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes

Diabetic Medicine

Volumn 28, Issue 12, 2011, Pages 1520-1524

  Kerr, D ^a   Partridge, H ^a   Knott, J ^a   Thomas, P W ^a  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

Diabetes; HbA1c; Mortality; Type 2

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; COMMUNITY CARE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEALTH SERVICE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; METABOLISM; MIDDLE AGED; ONSET AGE; PREDICTIVE VALUE; PREMATURE MORTALITY; STATISTICS;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MORTALITY, PREMATURE; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 81355154037     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03443.x     Document Type: Article

References (20)

1. Diabetes Atlas Committee. Diabetes Atlas. 3rd edn, Brussels, Belgium: International Diabetes Federation, 2009.
2. Olagiuri S, Borch-Johnsen K, Glumer C, Vistisen D. There really is an epidemic of type 2 diabetes. Diabetalogia 2005; 48: 1459-1463.
3. Gulliford M, Charlton J. Is relative mortality of type 2 diabetes decreasing. Am J Epidemiology 2009; 169: 455-461.
4. Charlton J, Radoslv L, Gulliford M. Explaining the decline in early mortality in men and women with type 2 diabetes. Diabetes Care 2008; 31: 1761-1766.
5. Kerr D, Knott J, Cavan D. The changing shape of diabetes. Practical Diabetes International; 2007; 24: 13-14.
6. Last accessed 10 October 2011
7. Cavan DA, Perrott T, Kerr D. Towards the paperless diabetes centre. Diabet Med 2001; 18: 101.
8. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Care 2003; 26: 688-696.
9. UK Prospective Diabetes Study (UKPDS) Group 23. BMJ 1998; 316: 823-828.
10. Turnball F, Abraira C, Anderson R, Byington R, Chalmers J, Duckworth W et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetalogia 2009; 52: 2288-2298.
11. Ray K, Seshasai S, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised control trials. Lancet 2009; 373: 1765-1772.
12. Davies M, Heller S, Skinner T, Campbell M, Carey M, Cradock S et al. Effectiveness of the diabetes education and self management for the on going and newly diagnosed type 2 diabetes: cluster controlled randomized trial. BMJ 2008; 336: 491-495.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
14. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
15. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
16. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
17. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
18. 1c in people with type 2 diabetes: a retrospective cohort study. Lancet 2010; 375: 481-489.
19. Mulnier H, Seaman H, Raleigh V, Soedamah-Muthu S, Colhoun H, Lawrenson R. Mortality in people with type 2 diabetes in UK. Diabetic Medicine 2006; 23: 516-521.
20. Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes. N Engl J Med 2003; 348: 383-393.